Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain

This publication has 10 references indexed in Scilit:

• Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine
  European Journal of Pharmacology: Environmental Toxicology and Pharmacology, 1992
• High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: Inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors
  Neuropharmacology, 1991
• Reduction of [³H]6‐nitroquipazine‐labelled 5‐hydroxytryptamine uptake sites in rat brain by 3,4‐methylenedioxymethamphetamine
  Fundamental & Clinical Pharmacology, 1990
• 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
  European Journal of Pharmacology, 1990
• Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
  Journal of Neurochemistry, 1990
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
  Journal of Neuroscience, 1988
• MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
  Pharmacology Biochemistry and Behavior, 1988
• Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus
  New England Journal of Medicine, 1987
• In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
  Biochemical Pharmacology, 1987
• Fluoxetine-induced attenuation of amphetamine self-administration in rats
  Life Sciences, 1986